文献速递肿瘤 PET/CT放射性药物与辐射防护

FDG PET/CT在主动脉移植物感染治疗控制中的作用

The role of FDG PET/CT in therapy control of aortic graft infection.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2018-06-11

该研究基于前瞻性血管移植物感染队列(VASGRA),纳入68例微生物学证实的主动脉移植物感染患者,共分析266次PET/CT(其中36次于停止抗菌治疗后完成)。结果显示较高的C反应蛋白与较高的SUVmax相关,PET/CT代谢、临床及CRP信息共同影响启动、升级、继续或停止抗生素治疗的决策。

要点

  • 68例主动脉移植物感染患者共接受266次PET/CT,其中36次在停止抗菌治疗后进行。
  • CRP每升高1个log10 mg/L,SUVmax调整系数为0.05(95%CI 0.02-0.08)。
  • 决定升级或继续抗生素治疗的PET/CT中,分别有12.5%和35.7% CRP值正常。

核心结论

  • 连续PET/CT可能在不久的将来影响主动脉移植物感染患者的临床决策。
  • 作者认为更多关于PET/CT用于主动脉移植物感染的研究可能为个体化治疗提供潜力。

研究设计与样本

  • 前瞻性血管移植物感染队列研究(VASGRA),纳入68例微生物学证实的主动脉移植物感染参与者,共贡献266次PET/CT,其中36次于停止抗菌治疗后完成。
  • 采用最大标准化摄取值(SUVmax)量化代谢活动,并分类为局灶性或弥漫性;使用广义估计方程拟合多变量线性回归模型探究与SUVmax随时间相关的因素。

主要发现

  • 较高的C反应蛋白与较高的SUVmax相关(每log10 mg/L调整系数0.05,95%CI 0.02-0.08)。
  • 决定启动抗生素治疗时:SUVmax中位数7.1,CRP中位数31.5 mg/L,100%为局灶性摄取。
  • 决定升级抗生素治疗时:SUVmax中位数9.5,CRP中位数31.5 mg/L,100%为局灶性摄取。
  • 决定继续抗生素治疗时:SUVmax中位数6.0,CRP中位数9.95 mg/L,90%为局灶性摄取。
  • 决定停止抗生素治疗时:SUVmax中位数4.3,CRP中位数3.5 mg/L,61%为局灶性摄取。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: 18F-FDG PET/CT (PET/CT) is a useful tool for the diagnosis of aortic graft infection (AGI), but has rarely been used to influence therapeutic decisions during follow-up. We aimed to study the role of PET/CT in the long-term monitoring of patients. METHODS: Participants of the prospective Vascular Graft Infection Cohort Study (VASGRA) were included if they had microbiologically proven AGI. We quantified the metabolic activity in PET/CT by using maximum standardized uptake value (SUVmax) and further classified it as being focal or diffuse. Multivariable linear regression models were fit using generalized estimating equations to investigate factors associated with SUVmax over time. RESULTS: Sixty-eight participants with AGI contributed to 266 PET/CTs including 36 examinations performed after stop of antimicrobial therapy. Higher C-reactive protein (CRP) (adjusted coefficient per log10 mg/L 0.05 [95% C.I. 0.02-0.08]) was associated with higher SUVmax. CRP, metabolic and clinical findings informed the decision to either start (medians of SUVmax 7.1 and CRP 31.5 mg/L; 100% focal uptake), escalate (SUVmax 9.5; CRP 31.5; 100% focal uptake), continue (SUVmax 6.0; CRP 9.95 mg/L; 90% focal uptake), or stop (SUVmax 4.3; CRP 3.5 mg/L; 61% focal uptake) antibiotic treatment. Of note, decisions to escalate or continue antibiotic treatment were taken despite normal CRP values in 12.5 and 35.7% of PET/CTs, respectively. CONCLUSIONS: Consecutive PET/CTs could influence the clinical decision-making in patients with AGI in the near future. More studies on the use of PET/CT in case of aortic graft infection may offer the potential for individualized treatment approaches. CLINICALTRIALS. GOV IDENTIFIER: NCT01821664.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Husmann L, Ledergerber B, Anagnostopoulos A, et al. The role of FDG PET/CT in therapy control of aortic graft infection. Eur J Nucl Med Mol Imaging. 2018. PMID: 29948106. doi:10.1007/s00259-018-4069-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。